« Previous Next » Schizophrenia Research
Volume 98, Issue 1 , Pages 66-78 , January 2008

In vitro and in vivo demonstration of risperidone implants in mice

C. Rabin
- Stanley Center for Experimental Therapeutics, Division of Neuropsychiatry, Department of Psychiatry University of Pennsylvania, United States
Y. Liang
- Stanley Center for Experimental Therapeutics, Division of Neuropsychiatry, Department of Psychiatry University of Pennsylvania, United States
R.S. Ehrlichman
- Stanley Center for Experimental Therapeutics, Division of Neuropsychiatry, Department of Psychiatry University of Pennsylvania, United States
A. Budhian
- Department of Materials Science and Engineering, University of Pennsylvania, United States
K.L. Metzger
- Stanley Center for Experimental Therapeutics, Division of Neuropsychiatry, Department of Psychiatry University of Pennsylvania, United States
C. Majewski-Tiedeken
- Stanley Center for Experimental Therapeutics, Division of Neuropsychiatry, Department of Psychiatry University of Pennsylvania, United States
K.I. Winey
- Department of Materials Science and Engineering, University of Pennsylvania, United States
S.J. Siegel
- Stanley Center for Experimental Therapeutics, Division of Neuropsychiatry, Department of Psychiatry University of Pennsylvania, United States
- Corresponding author. Division of Neuropsychiatry, Stanley Center for Experimental Therapeutics in Psychiatry, Translational Research Laboratories Rm. 2223, 125 South 31st St., University of Pennsylvania, Philadelphia, PA 19104, United States. Tel.: +1 215 573 0278; fax: +1 215 573 2041.